Stockscreener 앱 받기
0.011
50.45%
-0.0112
전일 마감가:
$0.0222
열려 있는:
$0.012
하루 거래량:
13,876
Relative Volume:
1.58
시가총액:
$N/A
수익:
$7.68M
순이익/손실:
$-42.95M
주가수익비율:
-0.000482
EPS:
-22.8421
순현금흐름:
$-36.62M
1주 성능:
-50.45%
1개월 성능:
+0.00%
6개월 성능:
-93.36%
1년 성능:
-95.82%
1일 변동 폭
$0.0025
$0.012
1주일 범위
$0.0025
$0.012
52주 변동 폭
$0.0025
$0.165
T 2 Biosystems Inc Stock (TTOO) Company Profile
TTOO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.011 | 0 | 7.68M | -42.95M | -36.62M | -22.84 |
|
TMO
Thermo Fisher Scientific Inc
|
538.92 | 202.69B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
209.06 | 151.03B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.40 | 50.99B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.92 | 40.00B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.55 | 34.98B | 15.70B | 1.24B | 2.01B | 6.9036 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-27 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2019-11-26 | 다운그레이드 | Janney | Buy → Neutral |
| 2019-08-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | 다운그레이드 | Janney | Buy → Neutral |
| 2019-05-16 | 개시 | Alliance Global Partners | Buy |
| 2019-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-06-01 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | 재확인 | H.C. Wainwright | Buy |
| 2018-05-29 | 재확인 | WBB Securities | Strong Buy |
| 2018-03-29 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-29 | 개시 | Goldman | Neutral |
| 2017-10-18 | 개시 | H.C. Wainwright | Buy |
| 2017-03-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | 재개 | Leerink Partners | Mkt Perform |
| 2016-11-02 | 재확인 | Cantor Fitzgerald | Buy |
| 2016-07-20 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | 재확인 | Canaccord Genuity | Buy |
| 2016-02-17 | 개시 | WBB Securities | Speculative Buy |
모두보기
T 2 Biosystems Inc 주식(TTOO)의 최신 뉴스
Why retail investors favor Rapid Micro Biosystems Inc. stock2025 Trading Volume Trends & Low Risk Entry Point Tips - nchmf.gov.vn
TTOO Interactive Stock Chart | T2 Biosystems, Inc. Stock - Yahoo Finance
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
GBS (NYSE:GBS) versus T2 Biosystems (NASDAQ:TTOO) Head-To-Head Survey - Defense World
Reviewing T2 Biosystems (NASDAQ:TTOO) & Titan Medical (NASDAQ:TMDIF) - Defense World
EBIT per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway - Investing News Network
Lyme Disease Pipeline 2025: In-Depth Clinical Trials Analysis And Emerging Therapies Report By Delveinsight Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Menafn.com
Reviewing Titan Medical (NASDAQ:TMDIF) and T2 Biosystems (NASDAQ:TTOO) - Defense World
Sepsis Diagnostics Market Poised for Remarkable Expansion by 2035, Reveals Prophecy Market Insights Study - newstrail.com
Will Retractable Technologies Inc. outperform the marketJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
T2 Biosystems, Inc. (NASDAQ:TTOO) Sees Significant Drop in Short Interest - Defense World
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates - MSN
Rapid Micro Biosystems Reports 15% Recurring Revenue Growth, Lands Major $45M Financing Deal - Stock Titan
Apyx Medical Strengthens Global Sales Leadership with Strategic Hires as New AYON System Launches - Stock Titan
Short Interest in T2 Biosystems, Inc. (NASDAQ:TTOO) Expands By 1,146.7% - Defense World
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells - Nature
Rapid Micro: Lake Street initiates coverage with Buy rating, PT $8. - AInvest
T2 Biosystems (NASDAQ:TTOO) versus InspireMD (NYSE:NSPR) Financial Review - Defense World
What analysts say about Rapid Micro Biosystems Inc. stockUnmatched profit potential - Autocar Professional
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Does Rapid Micro Biosystems Inc. stock pay reliable dividends200 Percent Profit Outlook - beatles.ru
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming Earnings Reports and Analyst Ratings Actions - AInvest
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Investor Network: T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above 50-Day Moving Average – Should You Sell? - Defense World
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Wall Street Zen Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200 Day Moving Average – Should You Sell? - Defense World
StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - The AM Reporter
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200-Day Moving Average – Time to Sell? - The AM Reporter
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - simplywall.st
Microbix Biosystems Leads These 3 TSX Penny Stocks To Watch - simplywall.st
Rapid Micro Biosystems, Inc. (RPID): Among the Hot Penny Stocks to Buy Now - Yahoo Finance
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Balance Sheet – OTC:TTOO - TradingView
T 2 Biosystems Inc (TTOO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
1.44%
자본화:
|
볼륨(24시간):